Progression of Parkinsonian signs in Parkinson disease

Archives of Neurology

Volumn 56, Issue 3, 1999, Pages 334-337

  Louis, Elan D ^a,b,c   Tang, Ming X ^a,b   Cote, Lucien ^a,b   Alfaro, Brenda ^b   Mejia, Helen ^b   Marder, Karen ^a,b  

^a Columbia University ^*  (United States)

^b Taub Institute for Research on Alzheimer's Disease and the Aging Brain and the Gertrude H Sergievsky Center   (United States)

^c NEUROLOGICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BRADYKINESIA; CONTROLLED STUDY; EXTRAPYRAMIDAL SYMPTOM; FEMALE; GAIT DISORDER; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; PARKINSONISM; PRIORITY JOURNAL; RIGIDITY; SCORING SYSTEM; TREMOR;

EID: 0033029930     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.56.3.334     Document Type: Article

References (25)

1. Parkinson J. An Essay on the Shaking Palsy. London, England: Whittingham & Rowland; 1817.
2. Hoehn MM, Yahr MD. Parkinsonism: onset, progression, and mortality. Neurology. 1967;17:427-442.
3. Bonnet AM. Loria Y, Saint-Hilaire M-H, Lhermitte F, Agid Y. Does long-term aggravation of Parkinson's disease result from nondopaminergic lesions? Neurology. 1987;37:1539-1542.
4. Lee CS, Schulzer M, Mak EK, et al. Clinical observations on the rate of progression of idiopathic parkinsonism. Brain. 1994;117:501-507.
5. Goetz CG, Tanner CM, Shannon KM. Progression of Parkinson's disease with levodopa. Neurology. 1987;37:695-698.
6. Olanow CW, Hauser RA, Gauger L, et al. The effect of deprenyl and levodopa on the progression of Parkinson's disease. Ann Neurol. 1995;38:771-777.
7. Louis ED, Marder KM, Cote L. Tang M-X, Mayeux R. Mortality from Parkinson disease. Arch Neurol. 1997;54:260-264.
8. Mayeux R, Marder K, Cote L, et al. The frequency of idiopathic Parkinson's disease by age, ethnic group, and sex in northern Manhattan, 1988-1993. Am J Epidemiol. 1995;142:820-827.
9. Mayeux R, Denaro J, Hemenegildo N. et al. A population-based investigation of Parkinson's disease with and without dementia: relationship to age and gender. Arch Neurol. 1992;49:492-500.
10. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinicopathological study of 100 cases. J Neurol Neurosurg Psychiatry. 1992;55:181-184.
11. Hughes AJ, Ben-Shlomo Y. Kilford L, Lees AJ. What features improve the accuracy of clinical diagnosis in Parkinson's disease: a clinicopathological study. Neurology. 1992;42:1142-1146.
12. Ward CD, Gibb WR. Research diagnostic criteria for Parkinson's disease. Adv Neurol. 1990;53:245-248.
13. Stern MB. The clinical characteristics of Parkinson's disease and parkinsonian syndromes: diagnosis and assessment. In: Stern MB, Hurtig HI, eds. The Comprehensive Management of Parkinson's Disease. New York, NY: PMA Publishing Corp; 1978:34-39.
14. Richards M, Marder K, Cote L, Mayeux R. Interrater reliability and factor structure of the Unified Parkinson's Disease Rating Scale Motor Examination. Mov Disord. 1994;9:89-91.
15. Bureau of the Census. Census of Population and Housing. 1990: Summary Tape file 1. Washington, DC: Bureau of the Census; 1991. Technical documentation prepared by Bureau ot Census.
16. Schwab JF, England AC. Projection technique for evaluating surgery in Parkinson's disease. In: Gillingham FJ, Donaldson ML. eds. Third Symposium on Parkinson's Disease. Edinburgh. Scotland: E & S Livingstone Ltd; 1969:152-157.
17. Stern Y, Andrews H, Pittman J, et al. Diagnosis of dementia in a heterogeneous population: development of a neuropsychological paradigm-based diagnosis of dementia and quantified correction for the effects of education. Arch Neurol. 1992; 49:453-460.
18. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Revised Third Edition. Washington, DC: American Psychiatric Association; 1987.
19. Marder K, Tang M-X, Cote L. Stern Y, Mayeux R. The frequency and associated risk factors for dementia in patients with Parkinson disease. Arch Neurol. 1995; 52:695-701.
20. Liang KY, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika. 1986;73:13-22.
21. Marder K, Liu X, Stern Y, et al. Neurological signs and symptoms in a cohort of homosexual men followed for 4.5 years. Neurology. 1995;45:261-267.
22. Stern Y, Liu X, Marder K, et al. Neuropsychological changes in a prospectively followed cohort of intravenous drug users with and without HIV. Neuropsychiatry Neuropsychol Behav Neurol. 1996;9:83-90.
23. Zetusky WJ, Jankovic J, Pirozzolo FJ. The heterogeneity of Parkinson's disease: clinical and prognostic implications. Neurology. 1985;35:522-526.
24. Hughes AJ, Daniel SE, Balnkson S. Lees AJ. A clinicopathological study of 100 cases of Parkinson's disease. Arch Neurol. 1993;50:140-148.
25. Mortimer JA, Pirozzolo FJ, Hansen EC, Webster DD. Relationship of motor symptoms to intellectual deficits in Parkinson's disease. Neurology. 1982;32:133-137.